Preliminary studies on treating NSCLC patients demonstrated that lncRNA DLX6-AS1 knockdown inhibited cell proliferation, migration, invasion and initiated apoptosis targeting PRR11 in NSCLCs [37]. Here, DLX6 is linked to non-small cell lung carcinoma.